Other languages Elutia Inc.

Equities

ELUT

US05479K1060

Delayed Nasdaq Other stock markets 01:47:37 2024-05-28 pm EDT			5-day change	1st Jan Change
3.29 ^USD	+1.23%		-2.66%	+52.31%

May. 09	Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
Elutia Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07
Elutia Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07
Elutia Submits CanGaroo Antibiotic-Eluting Biomatrix for FDA Clearance	Dec. 18
Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Berkeley Biologics, LLC completed the acquisition of Orthobiologics business unit of Elutia Inc. for $34.6 million.	Nov. 07
Top Premarket Gainers	23-10-06
Wall Street Set to Open Marginally Lower as Fed Kicks Off September Policy Meeting	23-09-19
Equity Futures Trend Higher as Investors Expect No Rate Hike From Fed	23-09-19
Top Premarket Gainers	23-09-19
Elutia Sells Orthobiologics Business Unit For Up to $35 Million	23-09-18
Aziyo Biologics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Aziyo Biologics, Inc. Announces the Voluntary Recall of Its Viable Bone Matrix Products	23-07-13
Aziyo Biologics Says Interim Analysis of CanGaroo Envelope Study Supports Wound-Healing Benefits in Implant Patients	23-05-19
Aziyo Biologics, Inc. Presents Positive Clinical Data on Cangaroo® Biologic Envelope	23-05-19
Aziyo Biologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo's Cardiovascular Portfolio	23-04-21
Aziyo Biologics Signs Distribution Agreement With LeMaitre Vascular for Cardiovascular Portfolio	23-04-20
Aziyo Biologics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-22
Aziyo Biologics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Elutia Inc.

Equities

ELUT

US05479K1060

Other languages

Filters